| 1 |
Levy BD, Serhan CN. Resolution of acute inflammation in the lung[J]. Annu Rev Physiol, 2014, 76: 467-492.
|
| 2 |
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology[J]. Nature, 2014, 510(7503): 92-101.
|
| 3 |
Recchiuti A, Serhan CN. Pro-Resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation[J]. Front Immunol, 2012, 3: 298.
|
| 4 |
Gabbs M, Leng S, Devassy JG, et al. Advances in our understanding of oxylipins derived from dietary PUFAs[J]. Advances in Nutrition, 2015, 6(5): 513-540.
|
| 5 |
Duvall MG, Levy BD. DHA- andEPA-derivedresolvins，protectins，and maresins in airway inflammation[J]. Eur J Parmacol, 2015, pii: S0014-2999(15)30340-X.
|
| 6 |
Chandrasekharan JA, Sharma-Walia N. Lipoxins: nature's way to resolve inflammation[J]. J Inflamm Res, 2015, 8: 181-92.
|
| 7 |
Serhan CN, Dalli J, Colas RA, et al. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome[J]. Biochim Biophys Acta, 2015, 1851(4): 397-413.
|
| 8 |
Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation[J]. Nature Reviews Immunology, 2015, 16(1): 51-67.
|
| 9 |
Russell CD, Schwarze J. The role of pro-resolution lipid mediators in infectious disease[J]. Immunology, 2014, 141(2): 166-173.
|
| 10 |
Lucas CD, Dorward DA, Tait MA, et al. Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung[J]. Mucosal Immunology, 2014, 7(4):857-868.
|
| 11 |
Yang Y, Cheng Y, Lian QQ, et al. Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury[J]. Mediators Inflamm, 2013, 2013: 862628.
|
| 12 |
Jin SW1, Zhang L, Lian QQ, et al. treatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1[J]. Anesth Analg, 2007, 104(2): 369-77.
|
| 13 |
Jin sw, Mei HX, Lian QQ. Effect of lipoxin A4 on the expression of aquapodn-5 in rat alveolar TypeⅡcells treated with lipopolysaccharide[J]．Chin J Crit Care Med, 2009, 29(1): 38-41.
|
| 14 |
Qi W, Li H, Cai XH, et al. Lipoxin A4 activates alveolar epithelial sodium channel gama via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury[J]. Laboratory Investigation, 2015, 95(11): 1258-1268.
|
| 15 |
Wang Q, Zheng X, Cheng Y, et al. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na，K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury[J]. J Immunol, 2014, 192(8): 3765-3777.
|
| 16 |
Eickmeier O, Seki H, Haworth O, et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury[J]. Mucosal Immunol, 2012, 6(2): 256-266.
|
| 17 |
Gong J, Wu ZY, Qi H, et al. Maresin 1 mitigates lps-induced acute lung injury in mice[J]. Br J Pharmacol, 2014, 171(14): 3539-3550.
|
| 18 |
Kong X, Wu SH, Zhang L, et al. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin[J]. Mol Med Rep, 2015, 12(1): 895-904.
|
| 19 |
Planagumà A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma[J]. Am J Respir Crit Care Med, 2008, 178(6): 574-582.
|
| 20 |
Grumbach Y, Quynh N V, Chiron R, et al. LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells[J]. Am J Physiol Lung Cell Mol Physiol, 2009, 296(1): L101-L108.
|
| 21 |
Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases[J]. Allergol Int, 2015, 64(1): 27-34.
|
| 22 |
Ariel A, Fredman G, Sun YP, et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression[J]. Nature Immunol, 2006, 7(11): 1209-1216.
|
| 23 |
Krishnamoorthy N, Burkett PR, Dalli J, et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation[J]. J Immunol, 2015, 194(3): 863-867.
|
| 24 |
Wu SH, Wu XH, Lu C, et al. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor [J]. Am J Respir Cell Mol Biol, 2006, 34(1): 65-72.
|
| 25 |
Yang J, Eiserich JP, Cross C E, et al. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients [J]. Free Rad Biol Med, 2012, 53(1): 160-171.
|
| 26 |
Martin CR, Zaman MM, Gilkey C, et al. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury[J]. Plos One, 2014, 9(6): e98773.
|
| 27 |
Hsiao HM, Thatcher TH, Colas RA, et al. Resolvin D1 reduces emphysema and chronic inflammation[J]. Am J Pathol, 2015, 185(12): 3189-3201.
|
| 28 |
Takamiya R, Fukunaga K, Arita M, et al. Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress[J]. FEBS Open Bio, 2012, 2: 328-333.
|